Goodwin Procter advised Advanced Biologics in its merger with Isto Biologics. Isto Biologics, a portfolio company of TSCP and a global leader in regenerative and autologous...
You must be a Standard 1 Year member to access this content.
Goodwin is advising the Official Committee of Unsecured Creditors on the procedure. Novan, Inc. (Nasdaq: NOVN) and its wholly owned subsidiary, EPI Health, LLC, announced that it...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Medipost Co. on the deal. Medipost Co. announced its strategic agreement with OmniaBio, Inc., a subsidiary of the Centre for Commercialization of Regenerative Medicine...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Apollo Intelligence on the deal. Apollo Intelligence announced its sale to Frazier Healthcare Partners. Apollo will continue to focus on elevating industry standards for...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and Gernandt & Danielsson advised Cint Group AB on the deal, while Goodwin Procter represented Lucid Holdings, LLC. Cint Group AB (publ), a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Spyce on the deal. sweetgreen, the mission-driven brand serving healthy food at scale, announced its plans to acquire Spyce, the Boston-based restaurant company powered...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Omega Funds on the deal. Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company exploiting a broad DDR-based platform and small...
You must be a Standard 1 Year member to access this content.
